Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $1.79 (+3.47%), Market cap $0.01B, 52-week low–high $0.25 ~ $9.40.
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidi
Financial statements, price targets, institutional (13F) holdings and related news for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares are updated in real time on BlackAll Trade.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares trades at $1.79 (+3.47%). Real-time quotes and charts are available on BlackAll Trade.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares has a market cap of about $0.01B.
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures a